Logo image of CJR-B.CA

CORUS ENTERTAINMENT INC-B SH (CJR-B.CA) Stock Fundamental Analysis

Canada - TSX:CJR-B - CA2208741017 - Common Stock

0.09 CAD
-0.01 (-5.26%)
Last: 10/10/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, CJR-B scores 2 out of 10 in our fundamental rating. CJR-B was compared to 15 industry peers in the Media industry. Both the profitability and financial health of CJR-B have multiple concerns. CJR-B has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CJR-B has reported negative net income.
In the past year CJR-B had a positive cash flow from operations.
In the past 5 years CJR-B reported 4 times negative net income.
In the past 5 years CJR-B always reported a positive cash flow from operatings.
CJR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCJR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

With a Return On Assets value of -4.53%, CJR-B perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
CJR-B has a Return On Invested Capital (6.78%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CJR-B is significantly below the industry average of 14.49%.
Industry RankSector Rank
ROA -4.53%
ROE N/A
ROIC 6.78%
ROA(3y)-24.86%
ROA(5y)-17.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.4%
ROIC(5y)7.93%
CJR-B.CA Yearly ROA, ROE, ROICCJR-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

CJR-B's Operating Margin of 9.73% is fine compared to the rest of the industry. CJR-B outperforms 80.00% of its industry peers.
CJR-B's Operating Margin has declined in the last couple of years.
CJR-B has a Gross Margin of 54.00%. This is in the better half of the industry: CJR-B outperforms 80.00% of its industry peers.
CJR-B's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.73%
PM (TTM) N/A
GM 54%
OM growth 3Y-17.74%
OM growth 5Y-11.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.57%
GM growth 5Y-2.57%
CJR-B.CA Yearly Profit, Operating, Gross MarginsCJR-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

2

2. Health

2.1 Basic Checks

CJR-B has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
CJR-B has about the same amout of shares outstanding than it did 1 year ago.
CJR-B has less shares outstanding than it did 5 years ago.
CJR-B has a worse debt/assets ratio than last year.
CJR-B.CA Yearly Shares OutstandingCJR-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CJR-B.CA Yearly Total Debt VS Total AssetsCJR-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of -1.53, we must say that CJR-B is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.53, CJR-B is in line with its industry, outperforming 46.67% of the companies in the same industry.
The Debt to FCF ratio of CJR-B is 31.40, which is on the high side as it means it would take CJR-B, 31.40 years of fcf income to pay off all of its debts.
CJR-B has a Debt to FCF ratio (31.40) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 31.4
Altman-Z -1.53
ROIC/WACC1.64
WACC4.13%
CJR-B.CA Yearly LT Debt VS Equity VS FCFCJR-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

CJR-B has a Current Ratio of 0.73. This is a bad value and indicates that CJR-B is not financially healthy enough and could expect problems in meeting its short term obligations.
CJR-B has a worse Current ratio (0.73) than 60.00% of its industry peers.
A Quick Ratio of 0.73 indicates that CJR-B may have some problems paying its short term obligations.
CJR-B has a worse Quick ratio (0.73) than 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.73
CJR-B.CA Yearly Current Assets VS Current LiabilitesCJR-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

0

3. Growth

3.1 Past

The earnings per share for CJR-B have decreased strongly by -200.00% in the last year.
Measured over the past years, CJR-B shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -43.12% on average per year.
CJR-B shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.09%.
CJR-B shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.52% yearly.
EPS 1Y (TTM)-200%
EPS 3Y-61.41%
EPS 5Y-43.12%
EPS Q2Q%160%
Revenue 1Y (TTM)-13.09%
Revenue growth 3Y-6.28%
Revenue growth 5Y-5.52%
Sales Q2Q%-10.25%

3.2 Future

The Earnings Per Share is expected to decrease by -69.66% on average over the next years. This is quite bad
Based on estimates for the next years, CJR-B will show a decrease in Revenue. The Revenue will decrease by -7.76% on average per year.
EPS Next Y-412.44%
EPS Next 2Y-158.25%
EPS Next 3Y-69.66%
EPS Next 5YN/A
Revenue Next Year-12%
Revenue Next 2Y-9.59%
Revenue Next 3Y-7.76%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CJR-B.CA Yearly Revenue VS EstimatesCJR-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CJR-B.CA Yearly EPS VS EstimatesCJR-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

CJR-B reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CJR-B. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CJR-B.CA Price Earnings VS Forward Price EarningsCJR-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CJR-B is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CJR-B is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.51
EV/EBITDA 1.44
CJR-B.CA Per share dataCJR-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 -6

4.3 Compensation for Growth

A cheap valuation may be justified as CJR-B's earnings are expected to decrease with -69.66% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-158.25%
EPS Next 3Y-69.66%

0

5. Dividend

5.1 Amount

No dividends for CJR-B!.
Industry RankSector Rank
Dividend Yield N/A

CORUS ENTERTAINMENT INC-B SH

TSX:CJR-B (10/10/2025, 7:00:00 PM)

0.09

-0.01 (-5.26%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)06-26 2025-06-26/bmo
Earnings (Next)10-17 2025-10-17/amc
Inst Owners0.47%
Inst Owner ChangeN/A
Ins Owners3.57%
Ins Owner ChangeN/A
Market Cap17.65M
Analysts43.08
Price Target0.07 (-22.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)70.37%
Min EPS beat(2)-75.76%
Max EPS beat(2)216.51%
EPS beat(4)3
Avg EPS beat(4)61.36%
Min EPS beat(4)-75.76%
Max EPS beat(4)216.51%
EPS beat(8)5
Avg EPS beat(8)11.57%
EPS beat(12)6
Avg EPS beat(12)-150.88%
EPS beat(16)8
Avg EPS beat(16)-114.76%
Revenue beat(2)0
Avg Revenue beat(2)-2.94%
Min Revenue beat(2)-2.96%
Max Revenue beat(2)-2.93%
Revenue beat(4)0
Avg Revenue beat(4)-4.34%
Min Revenue beat(4)-7.81%
Max Revenue beat(4)-2.93%
Revenue beat(8)0
Avg Revenue beat(8)-4.09%
Revenue beat(12)0
Avg Revenue beat(12)-4.01%
Revenue beat(16)1
Avg Revenue beat(16)-3.38%
PT rev (1m)0%
PT rev (3m)-19.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.7%
EPS NY rev (1m)0%
EPS NY rev (3m)34.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF 0.51
P/OCF 0.37
P/B N/A
P/tB N/A
EV/EBITDA 1.44
EPS(TTM)-0.03
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)0.18
FCFY194.86%
OCF(TTM)0.24
OCFY267.04%
SpS5.94
BVpS-2.24
TBVpS-7.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.53%
ROE N/A
ROCE 9.42%
ROIC 6.78%
ROICexc 7.27%
ROICexgc 95.01%
OM 9.73%
PM (TTM) N/A
GM 54%
FCFM 2.95%
ROA(3y)-24.86%
ROA(5y)-17.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.4%
ROIC(5y)7.93%
ROICexc(3y)8.88%
ROICexc(5y)8.26%
ROICexgc(3y)101.91%
ROICexgc(5y)97.84%
ROCE(3y)11.67%
ROCE(5y)11.02%
ROICexcg growth 3Y19.08%
ROICexcg growth 5Y5.54%
ROICexc growth 3Y19.25%
ROICexc growth 5Y13.77%
OM growth 3Y-17.74%
OM growth 5Y-11.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.57%
GM growth 5Y-2.57%
F-Score5
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 31.4
Debt/EBITDA 1.53
Cap/Depr 2.16%
Cap/Sales 1.09%
Interest Coverage 1.57
Cash Conversion 6.7%
Profit Quality N/A
Current Ratio 0.73
Quick Ratio 0.73
Altman-Z -1.53
F-Score5
WACC4.13%
ROIC/WACC1.64
Cap/Depr(3y)2.34%
Cap/Depr(5y)2.46%
Cap/Sales(3y)1.13%
Cap/Sales(5y)1.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-200%
EPS 3Y-61.41%
EPS 5Y-43.12%
EPS Q2Q%160%
EPS Next Y-412.44%
EPS Next 2Y-158.25%
EPS Next 3Y-69.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.09%
Revenue growth 3Y-6.28%
Revenue growth 5Y-5.52%
Sales Q2Q%-10.25%
Revenue Next Year-12%
Revenue Next 2Y-9.59%
Revenue Next 3Y-7.76%
Revenue Next 5YN/A
EBIT growth 1Y-31.39%
EBIT growth 3Y-22.91%
EBIT growth 5Y-16.24%
EBIT Next Year13.37%
EBIT Next 3Y2.89%
EBIT Next 5YN/A
FCF growth 1Y-72.11%
FCF growth 3Y-23.78%
FCF growth 5Y-18.48%
OCF growth 1Y-66.62%
OCF growth 3Y-21.92%
OCF growth 5Y-17.58%